Helicobacter pylori Infection in Croatian Population: Knowledge, Attitudes and Factors Influencing Incidence and Recovery
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. Survey Questionnaire
2.3. Statistical Analysis
3. Results
3.1. Demographic Data
3.2. H. pylori Knowledge
3.3. Sources of Information on H. pylori
3.4. Attitudes about H. pylori Testing and Screening Programs
3.5. H. pylori Eradication Therapy
3.6. Factors Influencing Incidence of H. pylori Infection and Estimated Symptoms’ Improvement after the Treatment
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- McNicholl, A.G.; O’Morain, C.A.; Megraud, F.; Gisbert, J.P. Protocol of the European Registry on the management of Helicobacter pylori infection (Hp-EuReg). Helicobacter 2019, 24, e12630. [Google Scholar] [CrossRef] [PubMed]
- Kim, Y.A.; Cho, Y.J.; Kwak, S.G. The Association between Helicobacter pylori Infection and Irritable Bowel Syndrome: A Meta-Analysis. Int. J. Environ. Res. Public Health 2020, 17, 2524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hooi, J.K.Y.; Lai, W.Y.; Ng, W.K.; Suen, M.M.Y.; Underwood, F.E.; Tanyingoh, D.; Malfertheiner, P.; Graham, D.Y.; Wong, V.W.S.; Wu, J.C.Y.; et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology 2017, 153, 420–429. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, C.; Lin, T.H.; Lin, C.J.; Kuo, C.F.; Pai, B.C.; Cheng, H.T.; Lai, C.C.; Chen, T.H. A Noninvasive Risk Stratification Tool Build Using an Artificial Intelligence Approach for Colorectal Polyps Based on Annual Checkup Data. Healthcare 2022, 10, 169. [Google Scholar] [CrossRef]
- Bulbuloglu, E.; Dagmura, H.; Daldal, E.; Deresoy, A.; Bakir, H.; Ozsoy, U.; Saglam, A.I.; Demir, O. Can Simple Tests Prior to Endoscopy Predict the OLGA Stage of Gastritis? Healthcare 2020, 8, 230. [Google Scholar] [CrossRef]
- Hata, K.; Koyama, T.; Ozaki, E.; Kuriyama, N.; Mizuno, S.; Matsui, D.; Watanabe, I.; Uehara, R.; Watanabe, Y. Assessing the Relationship between Helicobacter pylori and Chronic Kidney Disease. Healthcare 2021, 9, 162. [Google Scholar] [CrossRef] [PubMed]
- Zahidin, M.A.; Mohd Noor, N.H.; Johan, M.F.; Abdullah, A.D.; Zulkafli, Z.; Edinur, H.A. A Review on Secondary Immune Thrombocytopenia in Malaysia. Healthcare 2021, 10, 38. [Google Scholar] [CrossRef]
- Liou, J.M.; Malfertheiner, P.; Lee, Y.C.; Sheu, B.S.; Sugano, K.; Cheng, H.C.; Yeoh, K.G.; Hsu, P.I.; Goh, K.L.; Mahachai, V.; et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus. Gut 2020, 69, 2093–2112. [Google Scholar] [CrossRef]
- Ferrara, P.; Conti, S.; Aguero, F.; Albano, L.; Masuet-Aumatell, C.; Ramon-Torrell, J.M.; Mantovani, L.G. Estimates of Cancer Mortality Attributable to Carcinogenic Infections in Italy. Int. J. Environ. Res. Public Health 2020, 17, 8723. [Google Scholar] [CrossRef]
- Graham, D.Y.; Megraud, F. Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy. Helicobacter 2021, 26, e12773. [Google Scholar] [CrossRef]
- Guevara, B.; Cogdill, A.G. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies. Dig. Dis. Sci. 2020, 65, 1917–1931. [Google Scholar] [CrossRef] [PubMed]
- Gisbert, J.P. Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review. Ther. Adv. Gastroenterol. 2020, 13, 1756284820968736. [Google Scholar] [CrossRef] [PubMed]
- Zhao, H.; Yan, P.; Zhang, N.; Feng, L.; Chu, X.; Cui, G.; Qin, Y.; Yang, C.; Wang, S.; Yang, K. The recurrence rate of Helicobacter pylori in recent 10 years: A systematic review and meta-analysis. Helicobacter 2021, 26, e12852. [Google Scholar] [CrossRef] [PubMed]
- Teng, T.Z.J.; Sudharsan, M.; Yau, J.W.K.; Tan, W.; Shelat, V.G. Helicobacter pylori knowledge and perception among multi-ethnic Asians. Helicobacter 2021, 26, e12794. [Google Scholar] [CrossRef]
- Hafiz, T.A.; D’Sa, J.L.; Zamzam, S.; Dionaldo, M.L.V.; Mubaraki, M.A.; Tumala, R.B. Helicobacter pylori Infection: Comparison of Knowledge between Health Science and Non-Health Science University Students. Int. J Environ. Res. Public Health 2021, 18, 8173. [Google Scholar] [CrossRef]
- Wang, L.; Chen, H.; Ding, L. The impact of health education on the self-care ability of patients with peptic ulcer disease. Int. J. Clin. Exp. Med. 2020, 13, 9005–9011. [Google Scholar]
- Wu, Y.; Su, T.; Zhou, X.; Lu, N.; Li, Z.; Du, Y. Awareness and attitudes regarding Helicobacter pylori infection in Chinese physicians and public population: A national cross-sectional survey. Helicobacter 2020, 25, e12705. [Google Scholar] [CrossRef]
- Cheng, H.; Hu, F.; Zhang, L.; Yang, G.; Ma, J.; Hu, J.; Wang, W.; Gao, W.; Dong, X. Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China. Helicobacter 2009, 14, 128–133. [Google Scholar] [CrossRef]
- Zhu, H.M.; Li, B.Y.; Tang, Z.; She, J.; Liang, X.Y.; Dong, L.K.; Zhang, M. Epidemiological investigation of Helicobacter pylori infection in elderly people in Beijing. World J. Clin. Cases 2020, 8, 2173–2180. [Google Scholar] [CrossRef]
- Dai, X.; Li, W. Impact of Education, Medical Services, and Living Conditions on Health: Evidence from China Health and Nutrition Survey. Healthcare 2021, 9, 1122. [Google Scholar] [CrossRef]
- Driscoll, L.J.; Brown, H.E.; Harris, R.B.; Oren, E. Population Knowledge, Attitude, and Practice Regarding Helicobacter pylori Transmission and Outcomes: A Literature Review. Front. Public Health 2017, 5, 144. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Koch, P.; Schillmoller, Z.; Nienhaus, A. How Does Health Literacy Modify Indicators of Health Behaviour and of Health? A Longitudinal Study with Trainees in North Germany. Healthcare 2021, 10, 2. [Google Scholar] [CrossRef] [PubMed]
- Malekafzali, H.; Eftekhari, M.B.; Hejazi, F.; Khojasteh, T.; Noot, R.H.; Falahat, K.; Faridi, T. The Effectiveness of Educational Intervention in the Health Promotion in Elderly people. Iran J. Public Health 2010, 39, 18–23. [Google Scholar] [PubMed]
- Sharit, J.; Czaja, S.J. Overcoming Older Adult Barriers to Learning Through an Understanding of Perspectives on Human Information Processing. J. Appl. Gerontol. 2020, 39, 233–241. [Google Scholar] [CrossRef]
- Nyssen, O.P.; Bordin, D.; Tepes, B.; Perez-Aisa, A.; Vaira, D.; Caldas, M.; Bujanda, L.; Castro-Fernandez, M.; Lerang, F.; Leja, M.; et al. European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21533 patients. Gut 2021, 70, 40–54. [Google Scholar] [CrossRef]
- Perkovic, N.; Mestrovic, A.; Bozic, J.; Ivelja, M.P.; Vukovic, J.; Kardum, G.; Sundov, Z.; Tonkic, M.; Puljiz, Z.; Vukojevic, K.; et al. Randomized Clinical Trial Comparing Concomitant and Tailored Therapy for Eradication of Helicobacter pylori Infection. J. Pers. Med. 2021, 11, 534. [Google Scholar] [CrossRef]
- Xie, Y.; Song, C.; Cheng, H.; Xu, C.; Zhang, Z.; Wang, J.; Huo, L.; Du, Q.; Xu, J.; Chen, Y.; et al. Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: A large-scale multicentre, prospective open cohort, observational study. Emerg. Microbes Infect. 2020, 9, 548–557. [Google Scholar] [CrossRef] [Green Version]
- Jukic, I.; Vukovic, J.; Rusic, D.; Bozic, J.; Bukic, J.; Leskur, D.; Perisin, A.S.; Modun, D. Adherence to Maastricht V/Florence consensus report for the management of Helicobacter pylori infection among primary care physicians and medical students in Croatia: A cross-sectional study. Helicobacter 2021, 26, e12775. [Google Scholar] [CrossRef]
- Jukic, I.; Rusic, D.; Vukovic, J.; Zivkovic, P.M.; Bukic, J.; Leskur, D.; Perisin, A.S.; Luksic, M.; Modun, D. Correlation of registered drug packs with Maastricht V/Florence Consensus Report and national treatment guidelines for management of Helicobacter pylori infection. Basic Clin. Pharmacol. Toxicol. 2020, 126, 212–225. [Google Scholar] [CrossRef]
- Leja, M.; Grinberga-Derica, I.; Bilgilier, C.; Steininger, C. Review: Epidemiology of Helicobacter pylori infection. Helicobacter 2019, 24 (Suppl. S1), e12635. [Google Scholar] [CrossRef] [Green Version]
- Venneman, K.; Huybrechts, I.; Gunter, M.J.; Vandendaele, L.; Herrero, R.; Van Herck, K. The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: A systematic review. Helicobacter 2018, 23, e12483. [Google Scholar] [CrossRef] [PubMed]
- Kang, J.M.; Kim, N.; Shin, C.M.; Lee, H.S.; Lee, D.H.; Jung, H.C.; Song, I.S. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: A three-year follow-up study in Korea. Helicobacter 2012, 17, 86–95. [Google Scholar] [CrossRef] [PubMed]
Characteristics | N | % |
---|---|---|
Age | ||
19–34 years | 492 | 43.5 |
35–60 years | 530 | 46.9 |
>60 years | 109 | 9.6 |
Sex | ||
Female | 860 | 76.0 |
Male | 270 | 23.9 |
Did not answer | 1 | 0.1 |
Education level | ||
Primary education (and below) | 6 | 0.5 |
Secondary education | 342 | 30.2 |
Specialty | 27 | 2.4 |
Bachelor’s degree | 158 | 14.0 |
Master’s degree (and above) | 597 | 52.8 |
Did not answer | 1 | 0.1 |
Residence | ||
Urban | 873 | 77.2 |
Suburban | 149 | 13.2 |
Rural | 92 | 8.1 |
Did not answer | 17 | 1.5 |
Occupation | ||
Chief executives, senior officials and legislators | 54 | 4.8 |
Science and engineering professionals | 275 | 24.3 |
Technicians and associate professionals | 86 | 7.6 |
Clerical support workers, service and sales workers | 141 | 12.5 |
Skilled agricultural, forestry and fishery workers | 4 | 0.4 |
Plant and machine operators, and assemblers | 6 | 0.5 |
Student | 203 | 17.9 |
Other | 362 | 32.0 |
Habits | ||
Long-term alcohol | 90 | 8.0 |
Long-term smoking | 266 | 23.5 |
Long-term high-fat diet | 245 | 21.7 |
Long-term sweets | 534 | 47.2 |
Long-term seafood | 78 | 6.9 |
Long-term preserved food | 37 | 3.3 |
Long-term coffee | 521 | 46.1 |
Long-term tea | 52 | 4.6 |
Participants heard of H. pylori | 940 | 83.1 |
Participants screened for H. pylori infection | 315 | 27.9 |
Participants with H. pylori infection | ||
Yes | 156 | 13.8 |
No | 784 | 69.3 |
Do not know | 158 | 14.0 |
Low (%) | Moderate (%) | High (%) | p * | |
---|---|---|---|---|
Overall | 130 (11.5) | 405 (35.8) | 596 (52.7) | |
Age | ||||
19–34 years | 64 (13.0) | 152 (30.9) | 276 (56.1) | 0.014 |
35–60 years | 55 (10.4) | 202 (38.1) | 273 (51.5) | |
>60 years | 11 (10.1) | 51 (46.8) | 47 (43.1) | |
Sex | ||||
Female | 68 (7.9) | 310 (36.0) | 482 (56.0) | <0.001 |
Male | 61 (22.6) | 95 (35.2) | 114 (42.2) | |
Education level | ||||
Primary education (and below) | 1 (16.7) | 2 (33.3) | 3 (50.0) | 0.238 |
Secondary education | 46 (13.5) | 129 (37.7) | 167 (48.8) | |
Speciality | 5 (18.5) | 12 (44.4) | 10 (37.0) | |
Bachelor’s degree | 12 (7.6) | 55 (34.8) | 91 (57.6) | |
Master’s degree (and above) | 66 (11.1) | 206 (34.5) | 325 (54.4) | |
Residence | ||||
Urban | 83 (9.5) | 317 (36.3) | 473 (54.2) | 0.011 |
Suburban | 14 (9.4) | 52 (34.9) | 83 (55.7) | |
Rural | 20 (21.7) | 34 (37.0) | 38 (41.3) | |
Occupation | ||||
Chief executives, senior officials and legislators | 5 (9.3) | 24 (44.4) | 25 (46.3) | <0.001 |
Science and engineering professionals | 29 (10.5) | 81 (29.5) | 165 (60.0) | |
Technicians and associate professionals | 7 (8.1) | 34 (39.5) | 45 (52.3) | |
Clerical support workers, service and sales workers | 19 (13.5) | 59 (41.8) | 63 (44.7) | |
Skilled agricultural, forestry and fishery workers | 2 (50.0) | 2 (50.0) | 0 (0.0) | |
Plant and machine operators, and assemblers | 2 (33.3) | 2 (33.3) | 2 (33.3) | |
Student | 19 (9.4) | 51 (25.1) | 133 (65.5) | |
Other | 47 (13.0) | 152 (42.0) | 163 (45.0) | |
Participants screened for H. pylori infection | ||||
Yes | 1 (0.3) | 103 (32.7) | 211 (67.0) | <0.001 |
No | 115 (14.4) | 300 (37.5) | 384 (48.1) |
Participants Screened for H. pylori Infection | N | % |
---|---|---|
Yes | 315 | 27.9 |
No | 799 | 70.6 |
Did not answer | 17 | 1.5 |
Questions for the patients who were not screened for H. pylori | ||
Reason for not being screened | ||
It is not included in hospital physical examination | 176 | 22.0 |
There are no obvious symptoms and I don’t want to check them | 377 | 47.2 |
I am young and not necessary to test it | 114 | 14.3 |
I am old and worry about the risk of screening | 6 | 0.8 |
Other | 119 | 14.9 |
Did not answer | 7 | 0.9 |
Support for H. pylori screening | ||
Yes | 597 | 74.7 |
No | 11 | 1.4 |
Neutrality | 187 | 23.4 |
Did not answer | 4 | 0.5 |
Questions for patients who were screened for H. pylori | ||
Which of the following methods would you choose to screen for Helicobacter pylori? | ||
Go and test H. pylori on my own | 101 | 32.1 |
Routine medical examinations when available | 181 | 57.5 |
Not clear | 23 | 7.3 |
Did not answer | 10 | 3.2 |
If you are infected with Helicobacter pylori, would you be advised to screen your family for Helicobacter pylori? | ||
Yes | 185 | 58.7 |
No | 52 | 16.5 |
Neutrality | 72 | 22.9 |
Did not answer | 6 | 1.9 |
What is your attitude towards Helicobacter pylori screening? | ||
No need to check | 4 | 1.3 |
Neutrality | 36 | 11.4 |
Supporting screening | 270 | 85.7 |
Did not answer | 5 | 1.6 |
If you are infected with Helicobacter pylori, will you eradicate it? | ||
Yes | 281 | 89.2 |
No | 5 | 1.6 |
Neutrality | 22 | 7.0 |
Did not answer | 7 | 2.2 |
If you are negative for Helicobacter pylori but your family is positive for Helicobacter pylori, do you recommend your family to eradicate it? | ||
Yes | 279 | 88.6 |
No | 4 | 1.3 |
No opinion | 31 | 9.8 |
Did not answer | 1 | 0.3 |
Participants with H. pylori Infection | N | % |
---|---|---|
Yes | 156 | 13.8 |
No | 784 | 69.3 |
Not clear | 158 | 14.0 |
Did not answer | 33 | 2.9 |
If you had an infection, did you receive a treatment? | ||
Yes | 149 | 95.5 |
No | 3 | 1.9 |
Not clear | 4 | 2.6 |
Did not answer | 0 | 0.0 |
Reasons for not receiving treatment | ||
Carrying H. pylori has no impact on health and life | 1 | |
Economic factors | 0 | |
Worry about side effects of drug | 1 | |
Fear of relapse after eradication | 0 | |
Other | 1 | |
Did not answer | 1 | |
Questions for patients who received treatment | ||
Treatment regimen included antibiotic | ||
Yes | 141 | 94.6 |
No | 1 | 0.7 |
Not clear | 7 | 4.7 |
Did not answer | 0 | 0.0 |
Received triple/quadruple eradication treatment | ||
Yes | 124 | 83.2 |
No | 10 | 6.7 |
Not clear | 15 | 10.1 |
Did not answer | 0 | 0.0 |
Duration of the treatment | ||
<7 days | 3 | 2.0 |
7–10 days | 38 | 25.5 |
11–14 days | 37 | 24.8 |
>14 days | 45 | 30.2 |
Not sure | 24 | 16.1 |
Did not answer | 2 | 1.3 |
Re-examination after eradication treatment | ||
Yes | 106 | 71.1 |
No | 35 | 23.5 |
Not sure | 8 | 5.4 |
Did not answer | 0 | 0.0 |
Reinfected after the treatment | ||
Yes | 23 | 15.4 |
No | 96 | 64.4 |
Not sure | 29 | 19.5 |
Did not answer | 1 | 0.7 |
Have you had any of the following adverse reactions during taking the medicine? | ||
Abdominal pain | 31 | 20.8 |
Diarrhea | 14 | 9.4 |
Dry mouth | 20 | 13.4 |
Constipation | 10 | 6.7 |
Other | 21 | 14.1 |
No adverse drug reactions | 87 | 58.4 |
Estimate symptoms’ improvement after the treatment | ||
Deterioration | 1 | 0.7 |
No change | 13 | 8.7 |
Slight improvement | 24 | 16.1 |
Improvement | 70 | 47.0 |
Complete improvement | 41 | 27.5 |
Did not answer | 0 | 0.0 |
Worry caused by treatment | ||
All the time | 5 | 3.4 |
Most of the time | 9 | 6.0 |
Sometimes | 48 | 32.2 |
Occasionally | 35 | 23.5 |
Never | 52 | 34.9 |
Did not answer | 0 | 0.0 |
I considered other treatment options due to unsatisfactory results of the original therapy | ||
All the time | 13 | 8.7 |
Most of the time | 10 | 6.7 |
Sometimes | 39 | 26.2 |
Occasionally | 29 | 19.5 |
Never | 57 | 38.3 |
Did not answer | 1 | 0.7 |
Do You Still Have the Following Symptoms after Treatment? | Very Often (%) | Often (%) | Sometimes (%) | Almost Never (%) | Never (%) | Did Not Answer (%) |
---|---|---|---|---|---|---|
Abdominal pain regardless of intensity | 9 (6.0) | 8 (5.4) | 46 (30.9) | 17 (11.4) | 17 (11.4) | 52 (34.9) |
Stomach (upper abdomen) fullness | 14 (9.4) | 22 (14.8) | 42 (28.2) | 9 (6.0) | 15 (10.1) | 47 (31.5) |
Belching or flatulence | 20 (13.4) | 30 (20.1) | 44 (29.5) | 7 (4.7) | 6 (4.0) | 42 (28.2) |
Vomiting | 2 (1.3) | 0 (0.0) | 19 (12.8) | 27 (18.1) | 35 (23.5) | 66 (44.3) |
Nausea | 7 (4.7) | 13 (8.7) | 44 (29.5) | 18 (12.1) | 19 (12.8) | 48 (32.2) |
Heartburn | 15 (10.1) | 23 (15.4) | 44 (29.5) | 18 (12.1) | 10 (6.7) | 39 (26.2) |
Bitter taste | 11 (7.4) | 14 (9.4) | 18 (12.1) | 23 (15.4) | 26 (17.4) | 57 (38.3) |
Lack of appetite | 6 (4.0) | 8 (5.4) | 17 (11.4) | 27 (18.1) | 31 (20.8) | 60 (40.3) |
You must give up eating some favorite food due to illness | 19 (12.8) | 16 (10.7) | 24 (16.1) | 18 (12.1) | 23 (15.4) | 49 (32.9) |
Be dissatisfied with your life | 3 (2.0) | 7 (4.7) | 22 (14.8) | 29 (19.5) | 27 (18.1) | 61 (40.9) |
Situation affecting the continuation of daily amateur activities | 8 (5.4) | 4 (2.7) | 19 (12.8) | 24 (16.1) | 33 (22.1) | 61 (40.9) |
The relationship with your relatives and friends is affected due to illness | 3 (2.0) | 4 (2.7) | 10 (6.7) | 31 (20.8) | 40 (26.8) | 61 (40.9) |
Restrictions on sexual life | 3 (2.0) | 2 (1.3) | 12 (8.1) | 30 (20.1) | 39 (26.2) | 63 (42.3) |
Insomnia | 8 (5.4) | 19 (12.8) | 17 (11.4) | 19 (12.8) | 30 (20.1) | 56 (37.6) |
Illness has forced you to adopt a separate diet | 27 (18.1) | 17 (11.4) | 25 (16.8) | 19 (12.8) | 16 (10.7) | 45 (30.2) |
Feel sad because of your illness | 10 (6.7) | 10 (6.7) | 16 (10.7) | 24 (16.1) | 32 (21.5) | 57 (38.3) |
Frustrated by your illness | 10 (6.7) | 9 (6.0) | 18 (12.1) | 22 (14.8) | 35 (23.5) | 55 (36.9) |
Feel nervous or afraid due to illness (such as fear of canceration, etc.) | 8 (5.4) | 12 (8.1) | 16 (10.7) | 25 (16.8) | 32 (21.5) | 56 (37.6) |
Factors Influencing Incidence of H. pylori Infection | Factors Influencing Estimated Symptoms’ Improvement Post Treatment | |||||
---|---|---|---|---|---|---|
Fisher’s Exact Test | Cramer’s V | p | Fisher’s Exact Test | Cramer’s V | p | |
Age | 47.730 | 0.146 | <0.001 | 11.644 | 0.192 | 0.204 |
Sex | 18.653 | 0.135 | <0.001 | 13.187 | 0.301 | 0.009 |
Residence | 2.243 | 0.033 | 0.676 | 3.635 | 0.088 | 0.971 |
Occupation | 48.631 | 0.149 | <0.001 | 34.070 | 0.24 | 0.083 |
Education level | 5.838 | 0.046 | 0.791 | 14.340 | 0.175 | 0.327 |
Experienced treatment adverse drug reactions | n/a | n/a | n/a | 3.459 | 0.154 | 0.48 |
Follow-up medical examination after the treatment | n/a | n/a | n/a | 3.074 | 0.087 | 0.974 |
Habits | ||||||
Seafood | 0.620 | 0.021 | 0.781 | 1.145 | 0.028 | 0.998 |
High-fat diet | 5.271 | 0.07 | 0.069 | 1.927 | 0.111 | 0.77 |
Coffee | 0.276 | 0.016 | 0.871 | 13.689 | 0.304 | 0.008 |
Preserved food | 0.819 | 0.03 | 0.601 | 3.109 | 0.11 | 0.772 |
Tea | 4.030 | 0.061 | 0.133 | 10.172 | 0.423 | <0.001 |
Alcohol | 6.086 | 0.076 | 0.041 | 4.313 | 0.131 | 0.639 |
Smoking | 2.408 | 0.046 | 0.312 | 9.531 | 0.263 | 0.036 |
Sweets | 0.915 | 0.029 | 0.632 | 1.557 | 0.102 | 0.818 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vrebalov Cindro, P.; Bukić, J.; Leskur, D.; Rušić, D.; Šešelja Perišin, A.; Božić, J.; Vuković, J.; Modun, D. Helicobacter pylori Infection in Croatian Population: Knowledge, Attitudes and Factors Influencing Incidence and Recovery. Healthcare 2022, 10, 833. https://doi.org/10.3390/healthcare10050833
Vrebalov Cindro P, Bukić J, Leskur D, Rušić D, Šešelja Perišin A, Božić J, Vuković J, Modun D. Helicobacter pylori Infection in Croatian Population: Knowledge, Attitudes and Factors Influencing Incidence and Recovery. Healthcare. 2022; 10(5):833. https://doi.org/10.3390/healthcare10050833
Chicago/Turabian StyleVrebalov Cindro, Pavle, Josipa Bukić, Dario Leskur, Doris Rušić, Ana Šešelja Perišin, Joško Božić, Jonatan Vuković, and Darko Modun. 2022. "Helicobacter pylori Infection in Croatian Population: Knowledge, Attitudes and Factors Influencing Incidence and Recovery" Healthcare 10, no. 5: 833. https://doi.org/10.3390/healthcare10050833
APA StyleVrebalov Cindro, P., Bukić, J., Leskur, D., Rušić, D., Šešelja Perišin, A., Božić, J., Vuković, J., & Modun, D. (2022). Helicobacter pylori Infection in Croatian Population: Knowledge, Attitudes and Factors Influencing Incidence and Recovery. Healthcare, 10(5), 833. https://doi.org/10.3390/healthcare10050833